mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
Lisitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.047 |
0.2 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.064 |
0.2 |
mRNA |
Mdivi-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.049 |
0.2 |
mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
Obatoclax Mesylate |
GDSC1000 |
pan-cancer |
AAC |
0.046 |
0.2 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.051 |
0.2 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |